Facilitated By

San Antonio Medical Foundation

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations


This is a randomized, double-blind, placebo-controlled phase 3 study designed to compare the OS between patients treated with HMA plus vadastuximab talirine (experimental arm) versus patients treated with HMA plus placebo (comparator arm). Patients will be randomized in a 1:1 manner to one of the study arms. Investigators may select either HMA (azacitidine or decitabine).

Brooke Army Medical Center
Email for information

A distinguishing trait of heme enzymes is that a high-valent iron-oxo species is the common oxidant for mediating a remarkable array of oxidation reactions. However, the conundrum is that each enzyme in general only promotes a specific type of reaction. How the reaction type is determined after formation of the key oxidant remains to be an unsolved question. Answers to this question have implications for our fundamental understanding of enzyme catalysis as well as de novo enzyme design and protein engineering.

The University of Texas at San Antonio
Liu, Aimin; Wherritt, Daniel; Griffith, Wendell; Schanze, Kirk; McHardy, Stanton